6-Aminohexanoic acid

Papers

1. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin,. Humphries, J.E., et al. Arterioscler. Thromb. 13, 48-55, (1993)

---

2. Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis. Krishnamurti, C., et al. Thromb. Res. Suppl. 73, 419-430, (1994)

---

3. Plasminogen interactions with platelets in plasma. Adelman, B., et al. Blood 72, 1530-1535, (1988)

---

4. Inhibition by ε-aminocaproic acid of the activation of the first component of the complement system,. Soter, N.A., et al. J. Immunol. 114, 928, (1975)

---

5. Catheptic carboxypeptidase B as a major component in "T-cell activating factor" of macrophages. Dessaint, J.P., et al. J. Immunopharmacol. 1, 399-414, (1979)

---

6. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. H. Schägger, G. von Jagow Anal. Biochem. 199, 223, (1991)

---

Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid. Klaus Albertshofer et al J. Med. Chem. 48, 6741-9, (2005)

---

Chemical genetics reveals a complex functional ground state of neural stem cells Diamandis, P., et. al. Nat. Chem. Biol. 3(5), 268-273, (2007)

---

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Lourdes Santana et al J. Med. Chem. 51, 6740-51, (2008)

---

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. R Scott Obach et al Drug Metab. Dispos. 36, 1385-405, (2008)

---

Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Francisco J Prado-Prado et al Bioorg. Med. Chem. 18, 2225-31, (2010)

---

Developing structure-activity relationships for the prediction of hepatotoxicity. Nigel Greene et al Chem. Res. Toxicol. 23, 1215-22, (2010)

---

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Denis Fourches et al Chem. Res. Toxicol. 23, 171-83, (2010)

---

A predictive ligand-based Bayesian model for human drug-induced liver injury. Sean Ekins et al Drug Metab. Dispos. 38, 2302-8, (2010)

---

Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1). Iris Thondorf et al Bioorg. Med. Chem. 19, 6409-18, (2011)

---

Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors. Silke Hack et al Eur. J. Med. Chem. 46, 1483-98, (2011)

---

Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps). Zhichao Liu et al PLoS Comput. Biol. 7, e1002310, (2011)

---

Merck 14,432

Beil. 4,IV,2695

Aldrich MSDS 1, 67:B / Corp MSDS 1 (1), 149:B / FT-IR 2 (1), 919:B / FT-IR 1 (1), 578:D / IR-Spectra (3), 345:F / IR-Spectra (2), 308:A / NMR-Reference 2 (1), 490:C / RegBook 1 (1), 659:G / Sax 6, 205 / Sigma FT-IR 1 (1), 33:B / Structure Index 1, 97:B:8